Prevention trial for HIV Infections
Official title El Camino HIV Prevention and Care Study
ClinicalTrials.gov ID: NCT07834853
What this study is testing
- What it's testing
- The study wants to see if the program improves HIV testing, use of PrEP, care visits, medication adherence, and viral control, and to learn about legal, social, and mental health factors that affect care.
- Who it's for
- Adults who are Latin American, live in Washington, DC or Oakland, California, and have unmet HIV prevention or care needs.
- What's involved
- Participants will receive legal help and a peer navigator to reduce fear and stress, attend regular visits, and may get HIV tests and medication support. Those on the wait‑list will receive the program later.
- Time commitment
- The study lasts 18 months, with visits and tests scheduled throughout that period.
- Time commitment: about 18 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Age 18 years or older
- Assigned male sex at birth
- Identifies as a Latin American man who has sex with men, transgender woman, or nonbinary person on the feminine spectrum
- Not a U.S. citizen
- Speaks Spanish or English
You likely can't join if
- Younger than 18 years
- Does not meet the inclusion criteria above
See the full eligibility criteria
- Age 18 years or older
- Assigned male sex at birth
- Identifies as a Latin American man who has sex with men, transgender woman, or nonbinary person on the feminine spectrum
- Not a U.S. citizen
- Speaks Spanish or English
- Resides in the Washington, DC metropolitan area or San Francisco Bay Area
- Willing to receive health and/or supportive services through participating study partners
- Willing to allow the study to obtain relevant medical record information
- Living with HIV and either not linked to HIV care, has missed an HIV care appointment within the past year, is not taking antiretroviral therapy (ART), or has a detectable viral load
- Younger than 18 years
- Does not meet the inclusion criteria above
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 18 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.